Why You Should Consider an Advanced Training Fellowship in Inflammatory Bowel Disease

It is an exciting time for the study of inflammatory bowel disease (IBD). When Burrill Bernard Crohn published his manuscript titled “Regional Ileitis: A Pathologic and Clinical Entity” in 1932 in the Journal of the American Medical Association, he likely could not have anticipated the subsequent intrigue and discoveries in the study of IBD. As a gastroenterology trainee, I have learned of the significant research and clinical opportunities in the field of IBD. Whether it is the discovery and implementation of new medications such as vedolizumab or ustekinumab, novel modalities to improve diagnosis including magnetic resonance enterography and fecal calprotectin, or the emergence of the “treat-to-target” approach to care, there is never a dull moment when learning about this disease. This excitement has prompted me to pursue advanced training in IBD, and encourage you to consider this, too.